Beacon Intelligence - About the company
Beacon Intelligence is an acquired company based in London (United Kingdom), founded in 2015 by Sarah McCaldin. It operates as a Company offering clinical trial data and analysis service. The company has 126 active competitors, including 30 funded and 10 that have exited. Its top competitors include companies like Dandelion Health, Genedata and OccamzRazor.
Company Details
Beacon Targeted Therapies provides data and analysis services for life science companies. The company has 2 main products ADC Trials Intelligence which provides comprehensive data and intelligence on every antibody conjugate clinical trial, and IOC trials which provide comprehensive data and intelligence on every IO combination trial. Their clientele includes Genentech, AbbVie and Pfizer.
- Website
- beacon-intelligence.com
- Email ID
- *****@hansonwade.com
- Phone Number
- +44 **********
- Registered Address
- EASTCASTLE HOUSE,27/28 EASTCASTLE STREET,LONDON,UNITED KINGDOM,W1W 8DH
Key Metrics
Founded Year
2015
Location
London, United Kingdom
Stage
Acquired
Ranked
24th among 126 active competitors
Employee Count
229 as on Jul 31, 2026
Similar Companies
Exit Details
Acquired by Corten Capital (Jun 30, 2026)
Legal entities associated with Beacon Intelligence
Beacon Intelligence is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
BEACON INTELLIGENCE LIMITED CIN: 11999310 , United Kingdom, Active | May 15, 2019 | - | 2 (As on May 31, 2023) | |
HANSON WADE LIMITED CIN: 6752216 , United Kingdom, Active | Nov 17, 2008 | £10M - £50M (As on Dec 31, 2018) | 146 (As on Dec 31, 2018) |
Beacon Intelligence's acquisition details
Beacon Intelligence got acquired by Corten Capital and Ampersand Capital on Jun 30, 2026.
Click here to take a look at Beacon Intelligence's acquisition in detail
Sign up to download Beacon Intelligence's company profile
Beacon Intelligence's funding and investors
Beacon Intelligence has not raised any funding rounds yet.
Beacon Intelligence's founders and board of directors
Founder? Claim ProfileThe founders of Beacon Intelligence is Sarah McCaldin. Tom Richardson is the CEO of Beacon Intelligence.
Here are the details of Beacon Intelligence's key team members:
- Sarah McCaldin: Co-Founder of Beacon Intelligence.
- Tom Richardson: CEO of Beacon Intelligence.
View details of Beacon Intelligence's Founder profiles and Board Members
Beacon Intelligence's employee count trend
Beacon Intelligence has 229 employees as of Jul 26. Here is Beacon Intelligence's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Beacon Intelligence's Competitors and alternates
Top competitors of Beacon Intelligence include Dandelion Health, Genedata and OccamzRazor. Here is the list of Top 10 competitors of Beacon Intelligence, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Dandelion Health 2020, New York City (United States), Series A | Provider of AI-powered real-world data platform for clinical development | $29.9M | 61/100 | |
2nd | Genedata 1997, Basel (Switzerland), Acquired | Software solutions for drug discovery, industrial biotechnology, and life science research | - | 56/100 | |
3rd | OccamzRazor 2015, San Francisco (United States), Series A | Platform to organize and analyze life science information to derive actionable insights | $6.1M | 56/100 | |
4th | Sinopia Biosciences 2014, San Diego (United States), Seed | Data-driven drug discovery using multi-omics, AI, and disease models | $2.82M | 52/100 | |
5th | Century Health 2023, Santa Monica (United States), Seed | AI-powered health tech company accelerating access to breakthrough treatments | $7M | 51/100 | |
6th | Syntekabio 2009, Sunnyvale (United States), Public | AI-driven drug discovery and development, SaaS platform, supercomputing center | $11.1M | 50/100 | |
7th | Perthera 2012, Mclean (United States), Series A | Personalized molecular cancer profiling through genomics and proteomics | $17.8M | 47/100 | |
8th | NashBio 2018, Nashville (United States), Unfunded | Provider of multimodal dataset for drug development | - | - | 44/100 |
9th | Roam 2013, San Mateo (United States), Series B | Machine learning platform for health data analysis | $22.4M | 43/100 | |
10th | Provider of semantic search platform for pharmaceutical and biotech research | $12.7M | 43/100 | ||
24th | Beacon Intelligence 2015, London (United Kingdom), Acquired | Company offering clinical trial data and analysis service | - | - | 35/100 |
Looking for more details on Beacon Intelligence's competitors? Click here to see the top ones
Beacon Intelligence's Investments and acquisitions
Beacon Intelligence has made no investments or acquisitions yet.
Reports related to Beacon Intelligence
Here is the latest report on Beacon Intelligence's sector:
News related to Beacon Intelligence
•
Oxford spin-out gets £96m of funding at launchThe Business Magazine•Jul 17, 2023•Beacon Intelligence, Syncona
•
•
•
Syncona launches new gene therapy company Beacon TherapeuticsBioPharma-Reporter•Jun 12, 2023•Syncona, Beacon Intelligence, Beacontherapeuticservices
•
•
Are you a Founder ?
FAQs about Beacon Intelligence
Explore our recently published companies
- Shockwavetherapymachine - Unfunded company
- Smience Life Science - Ahmedabad based, 2025 founded, Unfunded company
- Feedly - Lahore based, 2026 founded, Unfunded company
- Smbsurgical - Unfunded company
- Faribault - Faribault based, Unfunded company
- Bitago - Dubai based, 2021 founded, Unfunded company